Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0348 | ||||
Gene Name | SLC39A7 | ||||
Protein Name | Zinc transporter SLC39A7 | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
Synonyms | D6S115E; D6S2244E; H2-KE4; HKE4; Histidine-rich membrane protein Ke4; KE4; RING5; Really interesting new gene 5 protein; SLC39A7; Solute carrier family 39 member 7; ZIP7; Zinc transporter SLC39A7 | ||||
DT Family | Zinc (Zn(2+))-Iron (Fe(2+)) Permease (ZIP) Family ; | ||||
Tissue Specificity | Widely expressed. | ||||
Function | This transporter is zinc transporter which transports Zn(2+) from the endoplasmic reticulum/Golgi apparatus to the cytosol. Transport is stimulated by growth factors, such as EGF, and Ca(2+), as well as by exogenous Zn(2+). | ||||
Endogenous Substrate(s) | Zn2+ | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(α) Microbiota Influence of This DT |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
(δ) Epigenetic Regulation of This DT |
|||||
(ε) Exogenous Modulation of This DT |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
Molecular Transporting Profile of This DT | |||||
Full List of Drug(s) Transported by This DT |
|||||
Withdrawn, Discontinued or Preclinical Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
Zinc salts
|
Preclinical | Drug Info | Arthritis | FA5Z | [1] |
References | |||||
1 | A ZIP6-ZIP10 heteromer controls NCAM1 phosphorylation and integration into focal adhesion complexes during epithelial-to-mesenchymal transition. Sci Rep. 2017 Jan 18;7:40313. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.